LEXX Lexaria Bioscience Corp.

$0.59 -4.81%

Healthcare · Pharmaceutical Preparations

Lexaria Bioscience Corp. (LEXX) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $15 million. Shares last traded at $0.59, 78.0% below their 52-week high. Over the past year the stock is down 40.0%. Net profit margin is -1686.0%, below the peer median of -0.1%. Revenue grew 52.0% year over year.

Market Cap

$15M

Shares Out

24.8M

EPS (TTM)

$-1.05

P/E Ratio

—

P/S Ratio

20.56

P/B Ratio

2.20

Dividend / Share

—

Dividend Yield

—

52-Week High

$2.66

52-Week Low

$0.46

Volume

3,966

Avg Vol (3m)

3,374.825

Performance

-8.99%

-5.14%

-19.52%

-52.41%

YTD

-8.50%

-39.96%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

38.14

SMA (50)

$0.75

SMA (200)

$0.85

Price vs SMA50

-21.52%

Price vs SMA200

-31.13%

ATR (14)

$0.04

Financials

Revenue

$1M

Net Income

$-12M

Gross Margin

99.6%

Operating Margin

-1683.0%

Net Margin

-1686.0%

Return on Equity

-180.3%

Return on Assets

-183.5%

Current Ratio

26.88

Debt / Equity

0.04

Revenue Growth (YoY)

+52.0%

Latest reported annual period ending 2025-08-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q2 2026	$-0.13	2026-04-13
Q1 2026	$-0.07	2026-01-13
FY 2025	$-0.66	2025-11-28
Q3 2025	$-0.53	2025-07-14
Q2 2026	$-0.32	2026-04-13
Q1 2026	$-0.16	2026-01-13

Full earnings history →

Pharmaceutical Preparations peers

LEXX vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/S vs peers

20.56 / 3.54 med

+481% premium

Net margin vs peers

-1686.0% / -0.1% med

below median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.